Sharon A Singh
Associate Professor of Pediatrics
[email protected]

Available to mentor
Sharon A Singh
Clinical Associate Professor
  • Recent Publications
    • Recent Publications See All Publications
    • Journal Article
      Murine erythroid differentiation kinetics in vivo under normal and anemic stress conditions.
      Myers G, Wang Y, Wang Q, Friedman A, Sanchez-Martinez A, Liu X, Singh SA, Lim K-C, Khoriaty R, Engel JD, Yu L. Blood Adv, 2023 Oct 10; 7 (19): 5727 - 5732. DOI:10.1182/bloodadvances.2023010088
      PMID: 37552129
    • Proceeding / Abstract / Poster
      MODELING REMISSION IN A MURINE RPL5 MODEL OF DIAMOND BLACKFAN ANEMIA
      Deng K, SanchezMartinez A, Hammoud S, Liu X, Guan Y, Engel J, Singh S. PEDIATRIC BLOOD & CANCER, 2023 70: S137 - S137.
    • Journal Article
      Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder.
      Kadouh NK, Lang S, Shamoun M, Scott EL, Singh SA, Smith MA. Pediatr Blood Cancer, 2022 Aug; 69 (8): e29526 DOI:10.1002/pbc.29526
      PMID: 34962695
    • Journal Article
      Identification of novel γ-globin inducers among all potential erythroid druggable targets.
      Yu L, Myers G, Schneider E, Wang Y, Mathews R, Lim KC, Siemieniak D, Tang V, Ginsburg D, Balbin-Cuesta G, Singh SA, Phuwakanjana P, Jearawiriyapaisarn N, Khoriaty R, Engel JD. Blood Adv, 2022 Jun 14; 6 (11): 3280 - 3285. DOI:10.1182/bloodadvances.2021006802
      PMID: 35240686
    • Journal Article
      An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation.
      Yu L, Myers G, Ku C-J, Schneider E, Wang Y, Singh SA, Jearawiriyapaisarn N, White A, Moriguchi T, Khoriaty R, Yamamoto M, Rosenfeld MG, Pedron J, Bushweller JH, Lim K-C, Engel JD. Blood, 2021 Nov 4; 138 (18): 1691 - 1704. DOI:10.1182/blood.2021011682
      PMID: 34324630
    • Additional Scholarship
      An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
      Abusin G. 2021 Nov 19;
    • Additional Scholarship
      A Phase 2/3, Double-Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease
      Abusin G. 2021 Oct 23;
    • Journal Article
      A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond Blackfan Anemia
      Yu L, Lemay P, Ludlow A, Guyot M-C, Jones M, Mohamed FF, Saroya G-A, Panaretos C, Schneider E, Wang Y, Myers G, Khoriaty R, Li Q, Franceschi R, Engel JD, Kaartinen V, Rothstein TL, Justice MJ, Kibar Z, Singh SA. Blood Advances, 2021 Oct 26; 5 (20): 4167 - 4179.